A detailed history of Cypress Capital Management LLC (Wy) transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Cypress Capital Management LLC (Wy) holds 5,000 shares of CARA stock, worth $1,650. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,000
Previous 5,350 6.54%
Holding current value
$1,650
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$0.52 - $1.05 $182 - $367
-350 Reduced 6.54%
5,000 $4,000
Q4 2022

Feb 02, 2023

SELL
$8.88 - $12.77 $18,603 - $26,753
-2,095 Reduced 28.14%
5,350 $57,000
Q3 2022

Nov 14, 2022

SELL
$8.24 - $12.56 $70,822 - $107,953
-8,595 Reduced 53.58%
7,445 $70,000
Q1 2022

May 09, 2022

SELL
$9.94 - $12.65 $5,993 - $7,627
-603 Reduced 3.62%
16,040 $195,000
Q4 2021

Feb 11, 2022

BUY
$11.99 - $18.14 $199,549 - $301,904
16,643 New
16,643 $203,000
Q3 2021

Nov 04, 2021

SELL
$11.55 - $16.06 $193,381 - $268,892
-16,743 Closed
0 $0
Q2 2021

Aug 10, 2021

SELL
$12.38 - $29.19 $687,981 - $1.62 Million
-55,572 Reduced 76.85%
16,743 $239,000
Q1 2021

May 07, 2021

SELL
$15.07 - $21.71 $134,936 - $194,391
-8,954 Reduced 11.02%
72,315 $1.57 Million
Q4 2020

Jan 29, 2021

SELL
$12.72 - $16.16 $1.25 Million - $1.58 Million
-97,928 Reduced 54.65%
81,269 $1.23 Million
Q3 2020

Oct 28, 2020

SELL
$12.34 - $17.92 $8,921 - $12,956
-723 Reduced 0.4%
179,197 $2.51 Million
Q2 2020

Aug 11, 2020

SELL
$12.39 - $17.33 $421 - $589
-34 Reduced 0.02%
179,920 $3.08 Million
Q1 2020

May 06, 2020

SELL
$9.12 - $17.78 $37,674 - $73,449
-4,131 Reduced 2.24%
179,954 $2.38 Million
Q4 2019

Feb 03, 2020

BUY
$16.11 - $25.98 $2.97 Million - $4.78 Million
184,085 New
184,085 $2.97 Million
Q3 2018

Oct 31, 2018

SELL
$17.57 - $23.95 $1.31 Million - $1.78 Million
-74,445 Closed
0 $0
Q2 2018

Aug 08, 2018

BUY
$11.6 - $19.27 $863,562 - $1.43 Million
74,445 New
74,445 $1.43 Million

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $17.7M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Cypress Capital Management LLC (Wy) Portfolio

Follow Cypress Capital Management LLC (Wy) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Management LLC (Wy), based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Management LLC (Wy) with notifications on news.